A Phase I, 2-Part, Multicenter, First-In-Human Dose-Escalation And Dose-Expansion Study Of Ds-1103A With Trastuzumab Deruxtecan (T-Dxd) In Patients With Advanced Solid Tumors
DS-1103a;Trastuzumab Deruxtecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase I, 2-Part, Multicenter, First-In-Human Dose-Escalation And Dose-Expansion Study Of Ds-1103A With Trastuzumab Deruxtecan (T-Dxd) In Patients With Advanced Solid Tumors ### Output: DS-1103a;Trastuzumab Deruxtecan